Everolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomes
Vasileios F Panoulas,1 Ioannis Mastoris,2 Klio Konstantinou,1 Maurizio Tespili,3 Alfonso Ielasi3 1National Heart and Lung Institute, Imperial College London, London, UK; 2Interventional Cardiovascular Research and Clinical Trials, The Zena and Michael A Wiener Cardiovascular Institute, The Icahn Sch...
Saved in:
Main Authors: | Panoulas VF, Mastoris I, Konstantinou K, Tespili M, Ielasi A |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2015
|
Subjects: | |
Online Access: | https://doaj.org/article/8b7f165c63a9415a929f8a7c00dfdc9d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Everolimus-eluting coronary stents
by: Alejandro Saez, et al.
Published: (2010) -
Everolimus-eluting stents: update on current clinical studies
by: Allocco DJ, et al.
Published: (2011) -
The everolimus-eluting Xience stent in small vessel disease: bench, clinical, and pathology view
by: Sanchez OD, et al.
Published: (2014) -
New stent design for use in small coronary arteries during percutaneous coronary intervention
by: Juan F Granada, et al.
Published: (2010) -
Next generation drug-eluting stents: focus on bioabsorbable platforms and polymers
by: Brendan Doyle, et al.
Published: (2009)